AMNOG-Check 2017
Gesundheitsökonomische Analysen der Versorgung mit Arzneimittel-Innovationen
Nomos, 1. Edition 2017, 205 Pages
The product is part of the series
Gesundheitsökonomische Beiträge
Description
What do astronomical prices, mixed prices and the AMNOG paradox mean? Is the financing of statutory health insurance in Germany (GKV) at risk? Is there still the potential to save money? What is value-based pricing? What consequences has the ruling by the Higher Social Court of Berlin-Brandenburg regarding the lawfulness of mixed prices had? Are there already supply gaps for innovative drugs?
AMNOG-Check 2017 provides profound answers to these questions. After six years of AMNOG legislation, this study puts the new regulations to the test. It analyses early benefit assessment and price negotiations empirically up to the end of 2016.
Its authors, Dieter Cassel und Volker Ulrich, are proven experts in this field, having published numerous research articles and expert reports.
AMNOG-Check 2017 provides profound answers to these questions. After six years of AMNOG legislation, this study puts the new regulations to the test. It analyses early benefit assessment and price negotiations empirically up to the end of 2016.
Its authors, Dieter Cassel und Volker Ulrich, are proven experts in this field, having published numerous research articles and expert reports.
Bibliographical data
| Edition | 1 |
|---|---|
| ISBN | 978-3-8487-4546-3 |
| Subtitle | Gesundheitsökonomische Analysen der Versorgung mit Arzneimittel-Innovationen |
| Addition to subtitle | Schwerpunktthema: Gefährdungsmomente der GKV-Versorgung bei AMNOG-Präparaten |
| Publication Date | Nov 10, 2017 |
| Year of Publication | 2017 |
| Publisher | Nomos |
| Format | Softcover |
| Language | deutsch |
| Pages | 205 |
| Medium | Book |
| Product Type | Scientific literature |
Reviews
»Der Band ist in jedem Kapitel materialreich und bietet in Summe AMNOG-Kennern in Politik und Wissenschaft fundierte empirische und theoretische Analysen zu wichtigen Einzelfragen.«
Dr. Markus Frick, Pharmind - die pharmazeutische Industrie 3/2018, 398-399
»gibt der AMNOG-Check 2017 profunde Antworten.«
Management & Krankenhaus 6/2018, 12
Dr. Markus Frick, Pharmind - die pharmazeutische Industrie 3/2018, 398-399
»gibt der AMNOG-Check 2017 profunde Antworten.«
Management & Krankenhaus 6/2018, 12
Product safety information
Manufacturer of products offered under GPSR
Nomos Verlagsgesellschaft mbH & Co. KG
Waldseestraße 3 - 5
76530 Baden-Baden, Germany
service@nomos.de
www.nomos.de